Classification of CKD
CKD is classified based on eGFR and albuminuria (ACR) categories.
Prognosis and Frequency of Testing
Early identification and management of CKD can reduce progression and cardiovascular risk. CKD prognosis for mortality, CVD and kidney function progression is determined by eGFR and albuminuria (ACR).
Early prevention of CKD can reduce progression and cardiovascular risk. CKD prognosis for mortality, CVD and kidney function progression is determined by eGFR and albuminuria (ACR).
Comprehensive Annual Care Plan (CACP)
For physicians practicing in Alberta, Canada the template integrates CKD guidelines and resources.
Kidney Failure Risk Equation
This equation predicts the 2 year and 5 year risk of treated kidney failure (dialysis or transplantation).
Management of Elevated Serum Potassium
Elevated serum potassium can develop due to a variety of factors including use of certain medications and high dietary potassium intake among patients with CKD. The approach to management of elevated serum potassium is dependent upon the cause and the degree of elevation in the potassium.
Conservative Kidney Management Pathway
Conservative Kidney Management (CKM) is a treatment option for patients with advanced kidney disease (eGFR < 15) who are unlikely to benefit from dialysis.
Clinical practice guidelines
The content contained on the CKD Clinical Pathway website is based on current research, the following existing evidence-based clinical guidelines, and clinical consensus.
References used for the CKD Clinical Pathway website drug content.